JohannesCzerninMD
Nuclear Medicine • Los Angeles, CAProfessor, Molecular & Medical Pharmacology, UCLA School of Medicine Chief of the Ahmanson Translational Imaging Division at UCLA
Dr. Czernin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
Los Angeles, CA 90095Phone+1 310-301-6800Fax+1 310-267-0227
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 1994 - 1995
University of Vienna Faculty of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1996 - 2026- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Los Angeles Magazine Top Doctors 2018
Clinical Trials
- PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma Start of enrollment: 2006 Jan 01
- Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants Start of enrollment: 2004 May 04
- Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy Start of enrollment: 2004 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 237 citationsReporter gene imaging of targeted T cell immunotherapy in recurrent glioma.Khun Visith Keu, Timothy H. Witney, Shahriar S. Yaghoubi, Jarrett Rosenberg, Anita Kurien
Science Translational Medicine. 2017-01-18 - 271 citationsNoninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.Shahriar S. Yaghoubi, Michael C. Jensen, Nagichettiar Satyamurthy, Shradha Budhiraja, David S. Paik
Nature Clinical Practice. Oncology. 2009-01-01 - 293 citationsPredicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pi...Wei Chen, Sibylle Delaloye, Daniel H.S. Silverman, Cheri Geist, Johannes Czernin
Journal of Clinical Oncology. 2007-10-20
Press Mentions
JNM Maintains Strong Metrics in 2023 Journal Citation ReportsJuly 24th, 2024- UCLA Researchers Receive Grant from Prostate Cancer FoundationDecember 14th, 2022
- UCLA Health Earns Comprehensive Center of Excellence Designation for Radiopharmaceutical Therapy as Work Continues on New FacilityJune 29th, 2022
- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
